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Editor-in-Chief,
Journal of the American
College of Cardiologyrecently had the privilege of serving as the Samuel and Edith Marcus Visiting
Professor Lecturer at the University of Arizona. During the 2-day visit Frank
Marcus, the loving son of the honorees and my host, shared with me his feelings
egarding the need for greater control over the interaction between the medical industry
nd physicians. In particular, we discussed the issue of gifts from industry to physicians
uch as lunches, pens, and other paraphernalia. That discussion, along with some
iterature that Frank provided, stimulated me to organize my own thoughts on the
atter. Recognizing that the interaction has sometimes been inappropriate on the part
f both industry and physicians, I am concerned that the pendulum may be in the
rocess of over-swinging. I doubt that industry could gain control over the actions of
ost physicians with any gift, much less a pen or a piece of pizza.
Because most drugs and devices require a prescription, it is not surprising that medical
ompanies have always directed the bulk of these educational and promotional activities
o physicians. It has been reported that in 2004, drug companies spent $24 billion on
romotion, of which $16 billion was in free samples and $7.3 billion for gifts and meals,
early all of which went to physicians (1). In fact, only recently has direct-to-consumer
dvertising become prevalent, a concept to which many object (2). Over time it became
pparent that some promotional activities were geared more to influence than inform. So
n 2002, the pharmaceutical industry adopted guidelines for behavior between their
epresentatives and physicians. However, a number of authorities believe that this code is
nadequate.
Concern with the interaction between industry and physicians continued to mount.
t reached a peak in 2006 when, in a publication in the Journal of the American Medical
ssociation (JAMA), a group of 11 highly-respected medical authorities proposed a policy
o eliminate conflicts of interest between the health care industry and physicians to be
ed by academic medical centers (3). They recommended the elimination or modification
f practices, including small gifts, drug samples, continuing medical education, travel
xpenses, speakers’ bureaus and consulting, and research contracts. This coalition argued
hat industry activities often crossed the line between patient welfare and corporate
rofits, that even very small gifts influence behavior either consciously or subconsciously,
nd that full disclosure of potential conflicts is inadequate to address the issue. They
pecifically recommended that all gifts to physicians (zero dollar limit) should be
rohibited. They recommended modifications of industry support of continuing medical
ducation that they recognized would result in reduced contributions necessitating funds
rom other sources.
The JAMA article helped to galvanize a movement to prohibit gifts to physicians. The
niversity of Pennsylvania and Stanford joined Yale in prohibiting faculty and staff from
ccepting any gifts whatsoever from industry. The University of California at Davis will
mplement this policy this summer. The culmination was the awarding this past month
f a $6 million grant from the Pew Charitable Trust to a consortium of advocacy groups
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March 20, 2007:1220–2 Editor’s Pagend the Institute of Medicine as a Profession to fund a national campaign, called the
rescription Project, to restrict interactions between doctors and drug/device companies.
he goal of the Prescription Project is to extend the restrictions implemented by Yale,
enn, and Stanford to other academic institutions, physician organizations, and third-
arty payers.
No one can deny that some past excesses have existed in the interaction of health care
ndustry with doctors. Some activities were clearly targeted more for marketing than
ducation. I can remember instances earlier in my career when I was the guest of
harmaceutical companies at sporting events, theater, golf, and even the Kentucky
erby, sometimes without any educational component. So some tightening of behavior
as in order. Even absent such activities, who could be against the concept that
hysician decisions be based upon scientific evidence and always made in the best
nterests of the patient? This is motherhood and apple pie. It is obvious that
nappropriate behavior regarding continuing medical education, physician travel, and
host writing must be stopped. I only question whether a pen, note pad, or sandwich for
lunch or cath conference renders it impossible to make evidence-based decisions in the
atient’s interest.
I am aware of the arguments that even small gifts achieve influence. Psychosocial
esearch has shown that presents of any size stimulate a strong desire to reciprocate (3).
s has often been pointed out, drug/device companies would not continue to provide
ifts if they did not think that the practice was effective. Moreover, I agree entirely that
ccepting gifts sets a bad example and can lead to an unfavorable perception of the
edical community. Physicians, even house staff in this day and age, certainly are not
mong the neediest segments of society.
Nevertheless, I believe that other considerations must also be taken into account.
en lights, bagels, and other gifts are of very little value, and unlikely to have major
mpact. In addition, such “freebies” are virtually ubiquitous in most medical settings.
have used pens supplied by virtually every pharmaceutical company that sells cardiac
rugs, and I often find myself writing with instruments displaying the names of products
hat a cardiologist would never use. It seems hard to believe that any individual company
ould gain much influence by providing the same tokens as everyone else. I worry that a
ocus on this minor area may detract emphasis from the bigger problem areas in
ndustry–physician interaction. Right or wrong, small gifts may provide a significant
nducement for education. Years ago, I prohibited industry from providing food or drink
or a teaching conference held from 5:00 to 7:00 at night. However, I relented when it
ecame clear that attendance was much improved if food was available, even if greasy,
old, or tasteless. Clearly, these same perquisites could have been funded by other
ources. In addition, although other measures could have attained the same goal, none
ould be tension-free or enable funds to be used for other aspects of the program.
otating the industry representatives who provided food offset influence by any one
ompany.
I worry that the initiative to rigidly restrict interactions between industry and
hysicians may ignore a number of realities. A major goal of the initiative is to achieve
vidence-based medicine. However, industry representatives often are an important
ource of information, especially for busy practitioners. Authorities often view with alarm
he fact that physician prescriptions increase after talking to industry representatives.
owever, given the abundant evidence of underutilization of therapies of proven efficacy,
erhaps this behavior reflects appropriate action in the face of new evidence. Much of
he important new evidence regarding clinical management comes from randomized
ontrolled trials supported by industry; the 4S, GUSTO, and TIMI trials spring into
ind. There is a certain irony in restricting the interaction of representatives of the
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Editor’s Page March 20, 2007:1220–2ntities responsible for the new evidence. We should recognize that industrial support of
he medical enterprise is pervasive. Major scientific sessions are funded in part by
ndustrial participation. In fact, the very venue in which the coalition of experts
roposed the policy to eliminate conflicts of interest, that is a medical journal, contains
ubstantial industrial advertising. The role of industry in many aspects of the medical
nterprise is a reality; emphasizing some small issues of industry–physician interaction
iminishes the arguments for reform of more significant problems.
It is not the purpose of this essay to argue for more gifts to physicians from industry,
or do I contend that drug/device companies provide such gifts for purely altruistic
urposes. Rather, I am uncertain that such low-value objects are worthy of such a high-
rofile effort. Although it makes good press to prohibit all gifts to physicians from
ndustry, I am not sure that it accomplishes very much. Personally, I find it hard to
elieve that these ubiquitous, inexpensive trinkets and morsels significantly affect medical
ecision making. They may even do some good if they succeed in inducing doctors to
cquire good evidence upon which to base management. There is no question that there
re serious issues regarding the interaction of industry and physicians in many areas of
edicine, and these issues should be addressed. We should emphasize those conditions
hat could inappropriately influence physician behavior to achieve monetary goals. I just
o not believe that any physician would sell their soul for a pen.
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